HealthSpan Partners to acquire Surgery Partners in $5.7 billion all‑cash deal
HealthSpan Partners, an affiliate of Bon Secours Mercy Health, signed a definitive agreement to buy Surgery Partners for an enterprise value of about $5.7 billion. Public shareholders will receive $23.50 in cash per share, a premium of roughly 49% to the prior close. The transaction is expected to close in the first quarter of 2027, subject to shareholder and antitrust approvals, and will result in Surgery Partners’ delisting from Nasdaq. Bain Capital, which holds about 39% of the company, will roll its stake into equity of the combined entity.
Why it matters
The cash offer at $23.50 per share gives shareholders a sizable premium and will convert the public company into a private one, ending its Nasdaq listing. The deal also expands Bon Secours’ outpatient surgical network, potentially enhancing its growth prospects.
Key facts
- 1HealthSpan Partners announced an all‑cash transaction valued at approximately $5.7 billion in enterprise value. investing.com
- 2Public shareholders will receive $23.50 per share in cash. investing.com
- 3The offer represents a 49% premium to the previous session’s close of $15.75. financialcontent.com
- 4Bain Capital currently holds about 39% of Surgery Partners’ outstanding shares and will roll its stake into equity of the acquiring entity. investing.com
- 5The transaction is expected to close in the first quarter of 2027, pending shareholder and regulatory approvals. investing.com
- 6Upon completion, Surgery Partners will be delisted from the Nasdaq Stock Exchange. investing.com
Summary written by AlphAI AI Desk from 13 of 13 sources. Not investment advice. Figures are as stated by the linked sources.